shortagewatch

Home / Various / Ioversol

ATC V08AB07 · Contrast Media

Ioversol shortage

As of 31 Oct 2026, Ioversol has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 8 products.

Countries3/5
Products8packs or presentations
Short since28 Apr 20233.5 years ago
Earliest return2 Nov 2026company estimate
No return date0products
Main reasonIncreased demand
GermanyNo reported shortageItaly3 packs shortSpain2 packs shortAustriaNo reported shortageBelgium3 packs short

Timeline

ItalySpainBelgium
2024202520262028OPTIRAYOPTIRAYOPTIRAYOPTIRAYOPTIRAYOPTIRAYOPTIRAY ULTRAJECT 300 mg/ml SOLUCION INYECTAOPTIRAY ULTRAJECT 300 mg/ml SOLUCION INYECTABLE , 1 jeringa precargada de 100 mlOPTIRAY ULTRAJECT 350 mg/ml SOLUCION INYECTAOPTIRAY ULTRAJECT 350 mg/ml SOLUCION INYECTABLE , 1 jeringa precargada de 125 mlOptiray 350 mg I/ml (148,4 g/200 ml) inj. soOptiray 350 mg I/ml (148,4 g/200 ml) inj. sol. i.arter. vial 200 mlOptiray 350 mg I/ml (371 g/500 ml) inj. sol.Optiray 350 mg I/ml (371 g/500 ml) inj. sol. i.arter. vial 500 mlOptiray 350 mg I/ml (74,2 g/100 ml) inj. solOptiray 350 mg I/ml (74,2 g/100 ml) inj. sol. i.arter. vial 100 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITOPTIRAYGUERBET28 Apr 20237 Sep 2027Increased demand
Elevata richiesta: forniture discontinue
ITOPTIRAYGUERBET4 Dec 202423 Sep 2027Increased demand
Elevata richiesta/problemi produttivi: forniture discontinue
ITOPTIRAYGUERBET4 Dec 202423 Sep 2027Increased demand
Elevata richiesta/problemi produttivi: forniture discontinue
ESOPTIRAY ULTRAJECT 300 mg/ml SOLUCION INYECTABLE , 1 jeringa precargada de 100 mlGuerbet3 Jun 202617 Jan 2027Not stated
ESOPTIRAY ULTRAJECT 350 mg/ml SOLUCION INYECTABLE , 1 jeringa precargada de 125 mlGuerbet16 Aug 202611 Mar 2027Not stated
BEOptiray 350 mg I/ml (148,4 g/200 ml) inj. sol. i.arter. vial 200 mlGuerbet12 Oct 202611 Dec 2026Manufacturing problem
Delay in production
BEOptiray 350 mg I/ml (371 g/500 ml) inj. sol. i.arter. vial 500 mlGuerbet12 Oct 20262 Nov 2026Manufacturing problem
Delay in production
BEOptiray 350 mg I/ml (74,2 g/100 ml) inj. sol. i.arter. vial 100 mlGuerbet12 Oct 202611 Dec 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Iobitridol Iodixanol Iohexol Iomeprol Iopamidol